...
首页> 外文期刊>International Journal of Nanomedicine >The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy for head and neck squamous cell carcinoma
【24h】

The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy for head and neck squamous cell carcinoma

机译:纳米多柔比蛋白 - 吲哚菁绿色基质金属蛋白酶响应水凝胶在颈部鳞状细胞癌中的合成与应用

获取原文
           

摘要

Background: Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignancies, with high rates of mortality and morbidity worldwide. Owing to the special anatomical location of this tumor, an effective, minimally invasive treatment with low systemic toxicity is highly desirable. Hydrogels have shown great potential for tumor-targeting therapy, with excellent performance. However, there have been few reports on co-loading photosensitizers and chemotherapeutic drugs into hydrogels. In this study, we synthesized a nano doxorubicin-indocyanine green matrix metalloproteinase (MMP)-responsive hydrogel (denoted as NDIMH), combining chemotherapy and phototherapy, to achieve superior antitumor efficacy. Methods: First, NDIMH was synthesized and characterized by scanning electron microscopy and drug-release assays. Second, the photosensitivity properties and antitumor efficiency of this drug delivery system were studied in?vivo and in?vitro. Last, the imaging and biodistribution of NDIMH were monitored using the Maestro EX in?vivo imaging system. Results: The nanodrugs loaded into the smart hydrogel exhibited uniform size distribution, excellent size stability, and a sustained release in the presence of MMP-2. NDIMH showed ideal photosensitivity characteristics under light. NDIMH with 808 nm near-infrared (NIR) irradiation effectively inhibited the viability, invasion, and metastasis of SCC-15 in?vitro. After intratumoral injection of NDIMH with 808 nm NIR illumination, the hydrogels exhibited favorable synergistic antitumor efficacy and acceptable biosafety. Additionally, fluorescence imaging showed that NDIMH could significantly improve the retention of nanodrugs at the tumor site. Conclusion: The intratumoral injection of NDIMH with 808 nm NIR irradiation could be a promising chemophototherapy alternative for HNSCC.
机译:背景:头部和颈部鳞状细胞癌(HNSCC)是最常见的恶性肿瘤之一,全球死亡率和发病率高。由于这种肿瘤的特殊解剖所在地,具有低系统性毒性的有效,微创的治疗是非常理想的。水凝胶表现出肿瘤靶向治疗的巨大潜力,性能优异。然而,有很少有关于将光敏剂和化学治疗药物加入水凝胶中的报道。在这项研究中,我们合成了纳米多柔比蛋白 - 吲哚菁绿基质基质金属蛋白酶(MMP) - 响应水凝胶(表示为NDIMH),组合化疗和光疗法,实现优异的抗肿瘤功效。方法:首先,通过扫描电子显微镜和药物释放测定合成并表征NdimH。其次,研究了该药物递送系统的光敏性质和抗肿瘤效率?体内和体外。最后,使用Maestro EX进行监测NDIMH的成像和生物分布,体内成像系统。结果:装载到智能水凝胶中的纳米粒子表现出均匀的尺寸分布,优异的尺寸稳定性,并且在MMP-2存在下持续释放。 NDIMH在光线下显示出理想的光敏特性。具有808nm近红外(NIR)辐射的NDIMH有效地抑制了SCC-15的活力,侵袭和转移。在用808nm的NIR照射中妥善注射NDIMH后,水凝胶表现出良好的协同抗肿瘤功效和可接受的生物安全。另外,荧光成像表明,NdimH可以显着改善肿瘤部位的纳米粒子的保留。结论:具有808nm NIR辐射的NDIMH妥善注射NDIMH可能是HNSCC的有前途的化学疗法替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号